glp 1 ras Could GLP-1 Receptor Agonists Help Prevent Infections in People with Diabetes? A Nationwide Study Says Yes—At Least for the Lungs and Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA Researchers issue a warning that

Main Text Glucagon-like peptide-1 (GLP-1), a neuroendocrine hormone, is derived from a proglucagon precursor ( 1 ) and secreted by intestinal enteroendocrine L cells in response to nutrient intake ( 2 ), predominantly in the form of GLP-1(7-36) amide (henceforth GLP-1) ( 3 )

One of the most potent treatments among those medications is the glucagon-like peptide-1 receptor agonists

GLP-1 therapies, longevity protocols, and combined treatments delivered to your doorstep (if approved)

Comparative Weight Loss Efficacy The landmark trials for both drugs show them operating in the realm previously reserved for bariatric surgery

This is on the heels of FDAs approvals of Novo Nordisks Wegovy (semaglutide) in December 2025 and Eli Lillys Foundayo (orforglipron) in April 2026

Ask for it directly